BxPC3 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF1152
Target Cell Organism: Human
Target Cell Alternative Name: BxPC-3
Target Cell Name: BxPC3
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide BxPC3-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
BxPC3
Target Cell Organism
Human
Target Cell Background
BxPC-3 is a cell line exhibiting epithelial morphology that was isolated from the pancreas tissue of a 61-year-old, female patient with adenocarcinoma. This cell line can be used in cancer research.
Target Cell Alternative Name
BxPC-3
Related Diseases
Pancreas Adenocarcinoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
BxPC3-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry